Application no. and date | 15790211.5 (espacenet) (Federated) (European Patent Register), 20151028 | Patent/reg. no. and date | DK/EP 3212237, 20220105 | Publication date | 20170906 | Priority no. and date | GB 201419261, 20141029 | EP pub. no. and date |
EP 3212237 20170906 | Effective date | | Applicant/owner | Therakind Ltd., 314 Regents Park Road
London, Greater London N3 2JX, GB | Applicant ref. no. | P78718DK01 | Inventor | FRODSHAM, Michael, c/o Quay Pharma Quay House 28 Parkway Deeside Industrial Park
Flintshire CH5 2NS, GB, PENTON, Julie-Ann, c/o Therakind Ltd 314 Regents Park Road
London Greater London N3 2JX, GB | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61K 47/10 (2017.01) , A61K 47/12 (2006.01) , A61K 9/00 (2006.01) , A61P 17/00 (2006.01) , A61P 17/06 (2006.01) , A61P 19/02 (2006.01) , A61P 19/04 (2006.01) , A61P 19/08 (2006.01) , A61P 21/00 (2006.01) , A61P 25/00 (2006.01) , A61P 29/00 (2006.01) , A61P 31/10 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , A61P 37/06 (2006.01) | Title | METHOTREXATFORMULERING | Int. application no. | GB2015053231 | Int. publication no. | WO2016067024 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|